{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:39:40Z","timestamp":1785281980217,"version":"3.55.0"},"reference-count":38,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NCI","award":["R01CA254367"],"award-info":[{"award-number":["R01CA254367"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Over 70% of leiomyoma (LM) harbor MED12 mutations, primarily in exon 2 at c.130-131 (GG). Myometrial cells are the cell origin of leiomyoma, but the MED12 mutation status in non-neoplastic myometrial cells is unknown. In this study, we investigated the mutation burden of MED12 in myometrium. As traditional Sanger or even NGS sequencing may not be able to detect MED12 mutations that are lower than 0.1% in the testing sample, we used duplex deep sequencing analysis (DDS) to overcome this limitation. Tumor-free myometria (confirmed by pathology evaluation) were dissected, and genomic DNA from MED12 exon 2 (test) and TP53 exon 5 (control) were captured by customer-designed probe sets, followed by DDS. Notably, DDS demonstrated that myometrial cells harbored a high frequency of mutations in MED12 exon 2 and predominantly in code c.130-131. In contrast, the baseline mutations in other coding sequences of MED12 exon 2 as well as in the TP53 mutation hotspot, c.477-488 were comparably low in myometrial cells. This is the first report demonstrating a non-random accumulation of MED12 mutations at c.130-131 sites in non-neoplastic myometrial cells which provide molecular evidence of early somatic mutation events in myometrial cells. This early mutation may contribute to the cell origin for uterine LM development in women of reproductive age.<\/jats:p>","DOI":"10.3390\/cells13171432","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T03:51:06Z","timestamp":1724730666000},"page":"1432","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Somatic MED12 Mutations in Myometrial Cells"],"prefix":"10.3390","volume":"13","author":[{"given":"Yinuo","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pathology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Asif","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9834-8213","authenticated-orcid":false,"given":"Julie J.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-2793","authenticated-orcid":false,"given":"Jian-Jun","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pathology, Northwestern University, Chicago, IL 60611, USA"},{"name":"Department of Obstetrics and Gynecology, Northwestern University, Chicago, IL 60611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","article-title":"Uterine fibroids","volume":"369","author":"Bulun","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fertnstert.2010.08.049","article-title":"Proceedings from theNational Institute of Child Health and Human Development conference on the Uterine Fibroid Research Update Workshop","volume":"95","author":"Catherino","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"Makinen","year":"2011","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","article-title":"MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Heinonen, H.R., Pasanen, A., Heikinheimo, O., Tanskanen, T., Palin, K., Tolvanen, J., Vahteristo, P., Sjoberg, J., Pitkanen, E., and Butzow, R. (2017). Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-01199-0"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.12688\/f1000research.14227.2","article-title":"Factors targeting MED12 to drive tumorigenesis?","volume":"7","author":"Bullerdiek","year":"2018","journal-title":"F1000Research"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ng.3037","article-title":"Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma","volume":"46","author":"Lim","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Li, Y., Xu, X., Asif, H., Feng, Y., Kohrn, B.F., Kennedy, S.R., Kim, J.J., and Wei, J.J. (2022). Myometrial oxidative stress drives MED12 mutations in leiomyoma. Cell Biosci., 12.","DOI":"10.1186\/s13578-022-00852-0"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.fertnstert.2017.04.015","article-title":"Oxidative stress: A key regulator of leiomyoma cell survival","volume":"107","author":"Fletcher","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0891-5849(00)00358-0","article-title":"The level of typical biomarker of oxidative stress 8-hydroxy-2\u2032-deoxyguanosine is higher in uterine myomas than in control tissues and correlates with the size of the tumor","volume":"29","author":"Foksinski","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2017.10.003","article-title":"17\u03b2-Estradiol Directly Lowers Mitochondrial Membrane Microviscosity and Improves Bioenergetic Function in Skeletal Muscle","volume":"27","author":"Torres","year":"2018","journal-title":"Cell Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e1601132","DOI":"10.1126\/sciadv.1601132","article-title":"Dysfunctional MnSOD leads to redox dysregulation and activation of prosurvival AKT signaling in uterine leiomyomas","volume":"2","author":"Vidimar","year":"2016","journal-title":"Sci. Adv."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mrfmmm.2011.02.015","article-title":"Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis","volume":"711","author":"Ziech","year":"2011","journal-title":"Mutat. Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Olivier, M., Hollstein, M., and Hainaut, P. (2010). TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol., 2.","DOI":"10.1101\/cshperspect.a001008"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.csbj.2019.12.013","article-title":"The genomics of oxidative DNA damage, repair, and resulting mutagenesis","volume":"18","author":"Poetsch","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1038\/sj.onc.1206023","article-title":"Oxidative nucleotide damage: Consequences and prevention","volume":"21","author":"Sekiguchi","year":"2002","journal-title":"Oncogene"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0021-9258(18)48474-8","article-title":"8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions","volume":"267","author":"Cheng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2019.03.001","article-title":"A Compendium of Mutational Signatures of Environmental Agents","volume":"177","author":"Kucab","year":"2019","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chin, E.L., da Silva, C., and Hegde, M. (2013). Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations. BMC Genet., 14.","DOI":"10.1186\/1471-2156-14-6"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1017\/S1461145714000789","article-title":"Making sense of deep sequencing","volume":"17","author":"Goldman","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Peng, Q., Xu, C., Kim, D., Lewis, M., DiCarlo, J., and Wang, Y. (2019). Targeted Single Primer Enrichment Sequencing with Single End Duplex-UMI. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-41215-z"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14508","DOI":"10.1073\/pnas.1208715109","article-title":"Detection of ultra-rare mutations by next-generation sequencing","volume":"109","author":"Schmitt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/nprot.2014.170","article-title":"Detecting ultralow-frequency mutations by Duplex Sequencing","volume":"9","author":"Kennedy","year":"2014","journal-title":"Nat. Protoc."},{"key":"ref_24","first-page":"e57266","article-title":"Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease","volume":"134","author":"Dilliott","year":"2018","journal-title":"J. Vis. Exp."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.celrep.2019.05.109","article-title":"Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan","volume":"28","author":"Salk","year":"2019","journal-title":"Cell Rep."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cole, A.J., Dwight, T., Gill, A.J., Dickson, K.A., Zhu, Y., Clarkson, A., Gard, G.B., Maidens, J., Valmadre, S., and Clifton-Bligh, R. (2016). Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing. Sci. Rep., 6.","DOI":"10.1038\/srep26191"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","article-title":"Biological and therapeutic impact of intratumor heterogeneity in cancer evolution","volume":"27","author":"McGranahan","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/humrep\/deac183","article-title":"Single-cell sequencing reveals novel cellular heterogeneity in uterine leiomyomas","volume":"37","author":"Goad","year":"2022","journal-title":"Hum. Reprod."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1095\/biolreprod.105.048124","article-title":"Myometrial apoptosis: Activation of the caspase cascade in the pregnant rat myometrium at midgestation","volume":"74","author":"Shynlova","year":"2006","journal-title":"Biol. Reprod."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/0008-5472.CAN-07-6339","article-title":"Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia","volume":"68","author":"Mayer","year":"2008","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1210\/en.2014-1029","article-title":"ROS are critical for endometrial breakdown via NF-kappaB-COX-2 signaling in a female mouse menstrual-like model","volume":"155","author":"Wu","year":"2014","journal-title":"Endocrinology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/humrep\/dead020","article-title":"Racial differences in transcriptomics and reactive oxygen species burden in myometrium and leiomyoma","volume":"38","author":"Li","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ajog.2004.06.117","article-title":"Environmental exposures, toxicologic mechanisms, and adverse pregnancy outcomes","volume":"192","author":"Silbergeld","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1095\/biolreprod.116.143461","article-title":"Role of Stro1+\/CD44+ stem cells in myometrial physiology and uterine remodeling during pregnancy","volume":"96","author":"Mas","year":"2017","journal-title":"Biol. Reprod."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10865-008-9185-0","article-title":"Discrimination and racial disparities in health: Evidence and needed research","volume":"32","author":"Williams","year":"2009","journal-title":"J. Behav. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/EDE.0b013e3181567e92","article-title":"Perceived racial discrimination and risk of uterine leiomyomata","volume":"18","author":"Wise","year":"2007","journal-title":"Epidemiology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2105\/AJPH.2004.060749","article-title":"\u201cWeathering\u201d and age patterns of allostatic load scores among blacks and whites in the United States","volume":"96","author":"Geronimus","year":"2006","journal-title":"Am. J. Public Health"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/PSY.0000000000000788","article-title":"Pervasive Discrimination and Allostatic Load in African American and White Adults","volume":"82","author":"Baumhofer","year":"2020","journal-title":"Psychosom. Med."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/17\/1432\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:43:16Z","timestamp":1760110996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/17\/1432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":38,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["cells13171432"],"URL":"https:\/\/doi.org\/10.3390\/cells13171432","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]}}}